Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: OXALIPLATIN - , . Treffer: 3
2018
Hann, A; Nosalski, E; Hermann, PC; Egger, J; Seufferlein, T; Keller, F
Chemotherapeutic agents eligible for prior dosing in pancreatic cancer patients requiring hemodialysis: a systematic review
.
Clin Nephrol. 2018; 90(2):125-141
Doi: 10.5414/CN109327
Web of Science
PubMed
FullText
FullText_MUG
2017
Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691
Doi: 10.21873/anticanres.11617
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Hohla, F; Hopfinger, G; Romeder, F; Rinnerthaler, G; Bezan, A; Stättner, S; Hauser-Kronberger, C; Ulmer, H; Greil, R
Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.
Int J Oncol. 2014; 44(1):319-326
Doi: 10.3892/ijo.2013.2176
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG